Home › Obesity › Texas › McKinney
Obesity clinical trials in McKinney, TX
5 studies for Obesity are looking for participants at sites in and around McKinney (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
RecruitingPhase 3
- Texas Institute of Cardiology, McKinney
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Texas Institute of Cardiology, McKinney
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- North Dallas Research Associates, McKinney
- Texas Institute of Cardiology, McKinney
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- North Texas Research Associates, McKinney
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL40 studies
- New York City, NY39 studies
- San Antonio, TX39 studies
- Washington, DC34 studies
- Dallas, TX33 studies
- Orlando, FL33 studies
- Miami, FL28 studies
- Boston, MA26 studies
- Atlanta, GA26 studies
- Los Angeles, CA25 studies
- St. Louis, MO25 studies
Other studies in McKinney
- COPD7 studies
- Type 2 Diabetes6 studies
- Heart Failure6 studies
- Asthma4 studies
- Chronic Kidney Disease4 studies
- Cardiovascular Disease4 studies
- Interstitial Lung Diseases3 studies
- Atrial Fibrillation3 studies
- Graves Disease3 studies
- Atherosclerosis3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.